Glaukos (GKOS) EBT (QoQ) (2014 - 2026)
Glaukos (GKOS) EBT (QoQ) (2014 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.66 Bn | 197.06 Bn | 7.27 Bn |
| 2 | Stryker | 126.34 Bn | 122.86 Bn | 4.50 Bn |
| 3 | Medtronic | 119.31 Bn | 110.09 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.66 Bn | 47.40 Bn | 1.35 Bn |
| 6 | Dexcom | 35.13 Bn | 33.18 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.82 Bn | 31.71 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.24 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Glaukos | 10.99 Bn | 10.87 Bn | 151.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.18% |
| Mar 31, 2026 | 86.64% |
| Dec 31, 2025 | -802.73% |
| Sep 30, 2025 | 17.58% |
| Jun 30, 2025 | -8.92% |
| Mar 31, 2025 | 50.39% |
| Dec 31, 2024 | -69.18% |
| Sep 30, 2024 | 57.72% |
| Jun 30, 2024 | -24.10% |
| Mar 31, 2024 | 1.78% |
| Dec 31, 2023 | -35.48% |
| Sep 30, 2023 | 6.08% |
| Jun 30, 2023 | 5.40% |
| Mar 31, 2023 | -0.52% |
| Dec 31, 2022 | -24.59% |
| Sep 30, 2022 | 40.12% |
| Jun 30, 2022 | -900.30% |
| Mar 31, 2022 | 123.43% |
| Dec 31, 2021 | -478.39% |
| Sep 30, 2021 | 137.24% |